Apryl
GermanyWho owns Apryl?
Apryl is a German HealthTech company, now owned by Progyny, which acquired it in 2024 from Ventech and Breega.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
- ·Fully exited in 2024 to Progyny.
- ·Average hold across 2 realized cycles: 2 years.
Ownership history
2 ownership periods · co-invest detected
Ventech sold Apryl to Progyny in 2024 after 2 years.
Breega sold Apryl to Progyny in 2024 after 2 years.
More from Breega Venture II
Other portfolio companies in the same fund.
UK
France
Spain
US
PortugalMore PE-backed in HealthTech
Comparable healthtech deals from other GPs.
Questions
Who owns Apryl?
Apryl is now owned by Progyny, which acquired it in 2024 from Ventech and Breega.
When did Progyny acquire Apryl?
Progyny acquired Apryl in 2024, buying from Ventech and Breega.
Who did Apryl sell to?
Ventech and Breega sold Apryl to Progyny in 2024 (Trade Sale).
Who has owned Apryl over time?
Apryl has been through 2 private-equity ownership periods: Ventech · via Ventech Europe · 2022–2024 · sold to Progyny · (Trade Sale); Breega · via Breega Venture II · 2022–2024 · sold to Progyny · (Trade Sale).